{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:44:11Z","timestamp":1773470651661,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21172193"],"award-info":[{"award-number":["21172193"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["R2110297"],"award-info":[{"award-number":["R2110297"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bmc.2021.116306","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:29:29Z","timestamp":1625790569000},"page":"116306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Design, synthesis and biological evaluation of 2-styryl-5-hydroxy-4-pyrone derivatives and analogues as multiple functional agents with the potential for the treatment of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"44","author":[{"given":"Chenxian","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5347-431X","authenticated-orcid":false,"given":"Rong","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116306_b0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bmc.2021.116306_b0010","unstructured":"Latest statistics from www.alz.org."},{"key":"10.1016\/j.bmc.2021.116306_b0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","article-title":"Alzheimer\u2019s disease prevention: from risk factors to early intervention","volume":"9","author":"Crous-Bou","year":"2017","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.bmc.2021.116306_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","article-title":"Therapeutics of Alzheimer\u2019s disease: past, present and future","volume":"76","author":"Anand","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmc.2021.116306_b0025","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev-pharmtox-011613-135932","article-title":"Emerging therapeutics for Alzheimer\u2019s disease","volume":"54","author":"Chiang","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bmc.2021.116306_b0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2021.116306_b0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1755-5949.2010.00212.x","article-title":"Histamine pharmacology and new CNS drug targets","volume":"17","author":"Tiligada","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.bmc.2021.116306_b0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/jm100064d","article-title":"Histamine H3 receptor as a drug discovery target","volume":"54","author":"Berlin","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116306_b0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/jpet.110.166876","article-title":"Discovery of histamine H3 antagonists for the treatment of cognitive disorders and Alzheimer\u2019s disease","volume":"336","author":"Brioni","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2021.116306_b0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neuropharm.2015.05.007","article-title":"Neuronal histamine and cognitive symptoms in Alzheimer\u2019s disease","volume":"106","author":"Zlomuzica","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bmc.2021.116306_b0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/13543776.2014.848197","article-title":"New developments around histamine H3 receptor antagonists\/inverse agonists: a patent review (2010-present)","volume":"24","author":"Lazewska","year":"2014","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2021.116306_b0060","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s40265-016-0620-1","article-title":"Pitolisant: first global approval","volume":"76","author":"Syed","year":"2016","journal-title":"Drugs."},{"key":"10.1016\/j.bmc.2021.116306_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"Deture","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.bmc.2021.116306_b0070","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/cr300009x","article-title":"Bioinorganic chemistry of Alzheimer\u2019s disease","volume":"112","author":"Kasper","year":"2012","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2021.116306_b0075","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.neurobiolaging.2009.05.012","article-title":"13-Amyloid impairs axonal BDNF retrograde trafficking","volume":"32","author":"Poon","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bmc.2021.116306_b0080","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/01616412.2016.1209337","article-title":"Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior","volume":"38","author":"Sharma","year":"2016","journal-title":"Neurol Res"},{"key":"10.1016\/j.bmc.2021.116306_b0085","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/461895a","article-title":"Neuroscience: Alzheimer\u2019s disease","volume":"461","author":"Mucke","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2021.116306_b0090","doi-asserted-by":"crossref","first-page":"117996","DOI":"10.1016\/j.lfs.2020.117996","article-title":"Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions","volume":"256","author":"Abeysinghe","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.bmc.2021.116306_b0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cbpa.2012.01.016","article-title":"Metal-associated amyloid-\u03b2 species in Alzheimer's disease","volume":"16","author":"Pithadia","year":"2012","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.bmc.2021.116306_b0100","first-page":"1","article-title":"The efficacy and pharmacological mechanism of Zn7MT3 to protect against Alzheimer\u2019s disease","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2021.116306_b0105","doi-asserted-by":"crossref","first-page":"316523","DOI":"10.1155\/2013\/316523","article-title":"Oxidative stress and the pathogenesis of Alzheimer's disease","volume":"2013","author":"Zhao","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.bmc.2021.116306_b0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease","volume":"33","author":"Leon","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2021.116306_b0115","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.3390\/molecules25245891","article-title":"New multifunctional agents based on conjugates of 4-Amino-2,3-polymethylenequinoline and butylated hydroxytoluene for Alzheimer's disease treatment","volume":"25","author":"Makhaeva","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2021.116306_b0120","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res"},{"key":"10.1016\/j.bmc.2021.116306_b0125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/cn4002126","article-title":"Synthesis, biological evaluation, and computational studies of tri- and tetracyclic nitrogen-bridgehead compounds as potent dualacting AChE inhibitors and hH3 receptor antagonists","volume":"5","author":"Darras","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2021.116306_b0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.bbr.2015.10.022","article-title":"The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in rats","volume":"297","author":"Khan","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bmc.2021.116306_b0135","doi-asserted-by":"crossref","first-page":"12765","DOI":"10.1002\/anie.201706072","article-title":"Multitarget-directed ligands combining cholinesterase and monoamine oxidase inhibition with histamine H3R antagonism for neurodegenerative diseases","volume":"56","author":"Bautista-Aguilera","year":"2017","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmc.2021.116306_b0140","doi-asserted-by":"crossref","first-page":"6937","DOI":"10.1021\/acs.jmedchem.8b00848","article-title":"Marco-Contelles, Contilisant, a tetratarget small molecule for Alzheimer\u2019s disease therapy combining cholinesterase, monoamine oxidase inhibition, and H3R antagonism with S1R agonism profile","volume":"61","author":"Bautista-Aguilera","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116306_b0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/acschemneuro.5b00224","article-title":"Novel 1-Phenyl-3-hydroxy-4-pyridinone derivatives as multifunctional agents for the therapy of Alzheimer's Disease","volume":"7","author":"Sheng","year":"2016","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2021.116306_b0150","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1016\/j.bmc.2018.08.011","article-title":"Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's disease","volume":"26","author":"Cheng","year":"2018","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2021.116306_b0155","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00044-012-0094-y","article-title":"Synthesis of kojic acid-derived copper-chelating apoptosis inducing agents","volume":"22","author":"Chen","year":"2013","journal-title":"Med Chem Res."}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962100314X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096808962100314X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:14:51Z","timestamp":1760836491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096808962100314X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":31,"alternative-id":["S096808962100314X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116306","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of 2-styryl-5-hydroxy-4-pyrone derivatives and analogues as multiple functional agents with the potential for the treatment of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116306"}}